Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 19 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11576922

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  2. US 11576889

    Methods of identifying and treating patients with HIF-2 inhibitor resistance

    The Board of Regents of the University of Texas System · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  3. US 11576948

    Long-acting VEGF inhibitors for intraocular neovascularization

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  4. US 11566007

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  5. US 11564930

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  6. US 11560368

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  7. US 11560366

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  8. US 11555041

    Bridged bicyclic inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  9. US 11555055

    Peptide inhibitors of insulin-degrading enzyme

    The Regents of the University of California · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  10. US 11548899

    Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  11. US 11548888

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  12. US 11547687

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  13. US 11542275

    Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors

    Aurigene Discovery Technologies Limited · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  14. US 11541045

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  15. US 11542261

    Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  16. US 11541032

    Composition containing sumo inhibitor and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  17. US 11542242

    Substituted piperazines as selective HDAC1,2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  18. US 11534429

    Small molecule inhibitors of bacterial efflux pumps and methods of using same

    The Regents of the University of Colorado · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  19. US 11534439

    Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  20. US 11530236

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  21. US 11529347

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  22. US 11529390

    PCSK9 inhibitory polypolypeptides and methods of use

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  23. US 11524962

    Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted

  24. US 11518772

    Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.